Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours.
until further notice
SourceEuropean Journal of Cancer, 42, 1, (2006), pp. 50-54
Article / Letter to editor
Display more detailsDisplay less details
Radboud University Nijmegen Medical Centre
European Journal of Cancer
SubjectNCEBP 1: Molecular epidemiology; ONCOL 1: Hereditary cancer and cancer-related syndromes; ONCOL 3: Translational research; ONCOL 5: Aetiology, screening and detection; UMCN 1.1: Functional Imaging; UMCN 1.5: Interventional oncology
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.